This article was published in Law360 on September 25, 2017. © Copyright 2017, Portfolio Media, Inc., publisher of Law360. It is republished here with permission.
A Pennsylvania federal court dismissed Monday a health plan’s potential class action accusing more than a dozen major drugmakers of fixing the prices of generic drugs, saying the plan couldn't have relied on the alleged misconduct of the drugmakers when deciding how much it owed providers based on its own experience.
Pepper Hamilton represented West-Ward Pharmaceuticals Corp.